type here...

CATEGORIES

Press Release

LATEST

1...9101112Page 10 of 12

TRENDING

EDITORS CHOICE

Is Silmitasertib the Covid-19 Treatment Breakthrough We’ve Been Waiting for?

Medika Life -
Within 24 hours of the first dose of Silmitasertib the patient showed significant clinical improvement and the oxygen requirement was weaned to room air. The patient was discharged from the hospital five days after starting Silmitasertib.

Global Empowerment Mission in Partnership with Bethenny Frankel’s BStrong Initiative Align with NCS Group for Texas Aid Relief During The State of Emergency

Medika Life -
The LATEST mission is bringing three relief trucks to Texas with the first truck en route from Miami to Denton (The Cross Timbers Hope Center In Denton, TX) followed by Houston, TX on Tuesday (February 23)

Colchicine Shows 48% Reduction in Future Cardio Issues for Heart Attack Victims

Medika Life -
Early, in-hospital treatment with colchicine reduces the odds of future cardiovascular problems by 48% in people who have just survived a heart attack

GE HealthCare and Biofourmis Collaborate to Extend Patient Monitoring Outside the Hospital with Virtual Care-at-Home Solutions

Medika Life -
Collaboration supports the patient journey across the care continuum and eases transitions and care from the hospital to home

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories